โ† All CHT Flashcard Decks

Transplant Immunology Flashcards

6 cards from real CHT practice questions. Tap to flip, then mark Knew It or Still Learning โ€” missed cards come back until you master them.

Read the first 6 Transplant Immunology flashcards as text
  1. Which type of rejection occurs within minutes to hours after transplantation and is mediated by preformed donor-specific antibodies?

    Answer: Hyperacute rejection

    Hyperacute rejection is caused by preformed donor-specific antibodies that immediately activate complement and cause thrombosis of graft vasculature.

  2. Which immune cells are primarily responsible for acute cellular rejection?

    Answer: CD4+ and CD8+ T lymphocytes

    Acute cellular rejection is driven predominantly by host CD4+ and CD8+ T cells that recognize donor alloantigens as foreign.

  3. What is the 'indirect pathway' of allorecognition?

    Answer: Host T cells recognize donor peptides presented by self HLA on host APCs

    In the indirect pathway, donor HLA proteins are processed into peptides and presented by recipient APCs on self-HLA molecules to recipient T cells.

  4. Chronic allograft nephropathy is most closely associated with which long-term immunological mechanism?

    Answer: Persistent donor-specific antibody (DSA)-mediated injury

    Chronic antibody-mediated rejection driven by DSA leads to progressive microvascular injury, transplant glomerulopathy, and eventual graft loss.

  5. Which complement pathway is most directly activated by donor-specific antibodies (DSA) bound to graft endothelium?

    Answer: Classical complement pathway

    DSA bound to donor endothelial HLA antigens activate the classical complement pathway via C1q, leading to C4d deposition.

  6. What does a positive C4d staining on peritubular capillaries in a kidney biopsy indicate in the transplant setting?

    Answer: Antibody-mediated rejection (AMR)

    Peritubular capillary C4d deposition is a marker of complement activation by DSA and is a diagnostic criterion for antibody-mediated rejection.